Categories
Blood Cancer

KARE 11’s Boyd Huppert announces multiple myeloma diagnosis [Video]

KARE 11’s Boyd Huppert announces multiple myeloma diagnosis

The award-winning host of Land of 10,000 Stories shared his diagnosis and the road ahead with KARE 11 anchor, and longtime friend, Randy Shaver.

https://www.kare11.com/article/news/local/kare-11-reporter-boyd-huppert-reveals-cancer-diagnosis/89-cc1ebdba-d22e-483d-b08c-6f2fe17047d4

Welcome to the official YouTube channel of KARE 11 News. Subscribe to our channel for compelling and dramatic storytelling, award winning investigations, breaking news and information you can use.

Text your photos, videos and news tips to 763-797-7215.

» Subscribe to KARE 11 on YouTube: https://www.youtube.com/subscription_
» Watch more KARE 11 video: https://www.youtube.com/user/KARE11/v
» Visit KARE11.com: http://www.kare11.com/
» Download our app! https://www.kare11.com/appredirect/
» Find KARE 11 on Facebook: https://www.facebook.com/KARE11/
» Follow KARE 11 on Twitter: https://twitter.com/kare11
» Follow KARE 11 on Instagram: https://www.instagram.com/kare11/

Watch/Read More
Categories
Blood Cancer

Whole tumor cell vaccination for treatment of mouse lymphoma [Video]

Modified whole EL-4 lymphoma cells were used as vaccines to treat EL-4 lymphoma. The vaccines induced specific T and B cell immune responses to cure the lymphoma. Elevated Anti-tumor IgG can be used for identification of targeted neoantigens and developing new immunotherapy.

Categories
Blood Cancer

BELINDA: Tisagenlecleucel in B-cell NHL [Video]

Michael Bishop, MD, University of Chicago, Chicago, IL, discusses results from the Phase III BELINDA trial (NCT03570892), which assessed tisagenlecleucel (tisa-cel), a chimeric antigen receptor (CAR) T-cell therapy, in patients with aggressive B-cell non-Hodgkin lymphoma. The primary endpoint, which was event-free survival, was not met, and tisa-cel was not superior to the current standard of care. Dr Bishop highlights the time taken for the therapy to be administered, bridging therapy, and the dosage of lymphodepleting chemotherapy to be factors affecting the trial results. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Categories
Blood Cancer

House on the Rock Church | Healing Testimony: Carole - Blood Cancer [Video]

Carole R. shares how getting serious about her relationship with God moved her from multiple years of health issues and a cancer diagnosis to being almost fully healed of her sicknesses. Listen as Carole tells more in-depth about her faith growing in the midst of God healing her.A CHURCH WHERE YOU CAN BELONGWhether you’re a seasoned church veteran, are shopping around for a new place to call home or are questioning what it looks like to have faith in Jesus Christ, we want to walk with you on your faith journey. At House on the Rock Church we see ourselves not as a church building with members but as bridge builders with a unique opportunity to share the love of Christ to a hurting and broken world. Our heart is to dive into the community and show this love in a way that’s culturally relevant in our ever-changing society. Our diverse church community is full of families both big and small. Whether you’re new to following Jesus or have been walking with him all your life, we are ready to welcome you with loving and open arms. It would be a great honor and joy to worship and live this life with you.Get in Touch6560 Merritt Rd • Ypsilanti, MI 48197734.433.6080https://hotrockchurch.org/#healing #healingtestimony #testimony